- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06480747
Strength Training and Muscle Lipids (Strength-Lip)
August 14, 2025 updated by: University of Kansas Medical Center
The Effects of Strength Training on Neuromuscular Function and Muscle Lipids.
The purpose of this study is examine the effects of 8 weeks (3 days/week) of resistance exercise training in children 8 to 10 years of age on muscle strength and power, motor unit activation, and lipid profiles of the vastus lateralis.
Study Overview
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66103
- Hoglund Biomedical Imaging Center
-
Lawrence, Kansas, United States, 66045
- Neuromechanics Laboratory
-
Overland Park, Kansas, United States, 66213
- Exercise and Human Performance Laboratory
-
Overland Park, Kansas, United States, 66213
- Metabolic and Body Composition Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Healthy volunteer males and females ages 8 - 10 years.
Exclusion Criteria:
- No history or ongoing neuromuscular diseases.
- No history or ongoing musculoskeletal injuries.
- No history or ongoing disease that effects metabolism.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: Resistance exercise training
|
Participants will strength train via linear periodization resistance exercise training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in muscular power of the leg extensors, as measured with isokinetic strength testing.
Time Frame: Baseline, following the intervention (9 weeks)
|
The score will reflect the muscular power of the leg extensors.
The higher score, reflects greater muscular strength.
|
Baseline, following the intervention (9 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in thigh muscle cross-sectional area
Time Frame: Baseline, following the intervention (9 weeks)
|
Scores are measured cross-sectional area from ultrasound images.
The higher score, reflects greater muscle size of the leg extensors.
|
Baseline, following the intervention (9 weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in the fatty acid saturation levels of the extramyocellular lipids of the vastus lateralis, as measure with magnetic resonance spectroscopy
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect a saturation level of fatty acids in the extramyocellular lipid.
The higher score, reflects greater fatty acid saturation.
|
baseline, following the intervention (9 weeks)
|
|
Change from baseline in the fatty acid saturation levels of the intramyocellular lipids of the vastus lateralis, as measure with magnetic resonance spectroscopy
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect a saturation level of fatty acids in the intramyocellular lipid.
The higher score, reflects greater fatty acid saturation.
|
baseline, following the intervention (9 weeks)
|
|
Change from baseline in intramyocellular lipids of the vastus lateralis, as measure with magnetic resonance spectroscopy
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect a concentration.
The higher score, reflects more fat in the fibers.
|
baseline, following the intervention (9 weeks)
|
|
Change from baseline in extramyocellular lipids of the vastus lateralis, as measure with magnetic resonance spectroscopy
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect a concentration.
The higher score, reflects more fat in the fibers.
|
baseline, following the intervention (9 weeks)
|
|
Change from baseline in motor unit activation, as measured with surface electromyography decomposition.
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect the firing rates of recorded motor units.
The higher score, reflects greater motor unit activation.
|
baseline, following the intervention (9 weeks)
|
|
Change in total body lean mass, as measured with bioelectrical impedance analysis.
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect the lean mass.
The higher score, reflects greater lean mass.
|
baseline, following the intervention (9 weeks)
|
|
Change in total body fat mass, as measured with bioelectrical impedance analysis.
Time Frame: baseline, following the intervention (9 weeks)
|
The score will reflect the fat mass.
The higher score, reflects greater fat mass.
|
baseline, following the intervention (9 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2024
Primary Completion (Actual)
December 7, 2024
Study Completion (Actual)
December 7, 2024
Study Registration Dates
First Submitted
June 24, 2024
First Submitted That Met QC Criteria
June 24, 2024
First Posted (Actual)
June 28, 2024
Study Record Updates
Last Update Posted (Actual)
August 20, 2025
Last Update Submitted That Met QC Criteria
August 14, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY00160469
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.